Bexxar Alternatives Compared
Bexxar | Rituxan | Rituximab |
|
---|
Bexxar (iodine i 131 tositumomab) | Rituxan (rituximab) | Rituximab |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Non-Hodgkin's Lymphoma. Bexxar may also be used for purposes not listed in this medication guide. |
Prescription only
Rituxan is a CD20 monoclonal antibody that causes B-cells to self-destruct or disintegrate and may be used to treat Non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid... View more |
Prescription only
Rituximab is a CD20 monoclonal antibody that causes B-cells to self-destruct or disintegrate and may be used to treat Non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid... View more |
Related suggestions Non-Hodgkin's Lymphoma
|
|||||||
More about Bexxar | More about Rituxan (rituximab) | More about Rituximab | ||||||||
Ratings & Reviews | ||||||||||
Be the first to share your experience with this drug. |
Rituxan has an average rating of 8.3 out of 10 from a total of 44 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 12% reported a negative effect. |
Rituximab has an average rating of 7.7 out of 10 from a total of 146 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 15% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: Rituxan side effects in more detail. |
See also: rituximab side effects in more detail. |
|||||||||
Generic Availability | ||||||||||
N/A |
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Rituxan prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Form(s) Available | ||||||||||
N/A |
|
N/A |
||||||||
Brand Names | ||||||||||
N/A |
Other rituximab brands include: Riabni, Ruxience, Truxima | Riabni, Rituxan, Ruxience, Truxima | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
193 hours |
59.8 hours |
59.8 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category X
Not for use in pregnancy
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 281 drugs are known to interact with Bexxar:
|
A total of 170 drugs are known to interact with Rituxan:
|
A total of 170 drugs are known to interact with rituximab:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||
First Approval Date | ||||||||||
N/A |
N/A |
N/A |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
N/A |
||||||||||
Related Treatment Guide | ||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.